Australia's medical tech firm EchoIQ drops after rejection on key US application
06/10/2025 06:03
** Shares of Australia's EchoIQ EIQ.AX fall as much as 14.6% to A$0.175, biggest intraday pct drop since September 19 ** Medical technology co says it was unsuccessful in its application for a Category III Current Procedural Technology (CPT) code for EchoSolv AS in the US ** EchoSolv AS is an AI platform that helps with early identification of severe aortic stenosis patients ** CPT code set is used to track emerging technologies, procedures, and services and enables data collection on safety and effectiveness ** Stock is down 21.7% YTD, including the session's moves (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt